Dominika Bąk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dominika Bąk has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Adrianna Antoszewska
Uniwersytet Rzeszowski
6 shared publications - Julia Buszek
Uniwersytet Rzeszowski
6 shared publications - Piotr Czerniak
Uniwersytet Rzeszowski
6 shared publications - Weronika Bargiel
Uniwersytet Rzeszowski
6 shared publications - Halszka Wajdowicz
Uniwersytet Rzeszowski
5 shared publications - Mateusz Warzocha
Uniwersytet Rzeszowski
5 shared publications
Latest Publications
- Open Access
- 22 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 86, 67351
Infertility as a Contemporary Social and Therapeutic Challenge - A Literature Review
INTRODUCTION: Infertility is a multifactorial condition affecting both women and men, with substantial social, psychological, and medical implications. It arises from hormonal, anatomical, genetic, infectious, and lifestyle-related factors. AIM OF STUDY: This review aims to summarize current knowledge on the etiology, pathophysiology, and therapeutic approaches to infertility in both sexes, emphasizing major conditions. MATERIAL AND METHODS: A literature review was conducted analyzing peer-reviewed studies on reproductive health from PubMed and GoogleScholar. Both male and female infertility were considered, focusing on factors influencing gametogenesis, fertilization, embryo implantation and pregnancy outcomes. BASIC RESULTS: In women, infertility is influenced by endometriosis, which alters implantation through inflammatory and immunomodulatory mechanisms; PCOS, which disrupts hormonal balance and ovulation; and uterine fibroids, which impair myometrial contractility and endometrial receptivity. In men, infertility results from genetic and acquired causes, including azoospermia, varicocele, infections, and malignancies, with oxidative stress, antisperm antibodies, and dysbiosis contributing to impaired spermatogenesis and sperm transport. Lifestyle interventions, as well as surgical and pharmacological treatments, can improve reproductive outcomes. CONCLUSION: Infertility is a complex, interrelated condition requiring multidisciplinary management. Understanding biological, genetic, immunological and lifestyle factors is essential to optimize therapy, enhance conception, and increase live birth rates. Targeting modifiable factors such as diet, physical activity, and body weight is a promising adjunct to conventional treatment.
- 22 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 86, 67351
Open AccessInfertility as a Contemporary Social and Therapeutic Challenge - A Literature Review
INTRODUCTION: Infertility is a multifactorial condition affecting both women and men, with substantial social, psychological, and medical implications. It arises from hormonal, anatomical, genetic, infectious, and lifestyle-related factors. AIM OF STUDY: This review aims to summarize current knowledge on the etiology, pathophysiology, and therapeutic approaches to infertility in both sexes, emphasizing major conditions. MATERIAL AND METHODS: A literature review was conducted analyzing peer-reviewed studies on reproductive health from PubMed and GoogleScholar. Both male and female infertility were considered, focusing on factors influencing gametogenesis, fertilization, embryo implantation and pregnancy outcomes. BASIC RESULTS: In women, infertility is influenced by endometriosis, which alters implantation through inflammatory and immunomodulatory mechanisms; PCOS, which disrupts hormonal balance and ovulation; and uterine fibroids, which impair myometrial contractility and endometrial receptivity. In men, infertility results from genetic and acquired causes, including azoospermia, varicocele, infections, and malignancies, with oxidative stress, antisperm antibodies, and dysbiosis contributing to impaired spermatogenesis and sperm transport. Lifestyle interventions, as well as surgical and pharmacological treatments, can improve reproductive outcomes. CONCLUSION: Infertility is a complex, interrelated condition requiring multidisciplinary management. Understanding biological, genetic, immunological and lifestyle factors is essential to optimize therapy, enhance conception, and increase live birth rates. Targeting modifiable factors such as diet, physical activity, and body weight is a promising adjunct to conventional treatment.
- Open Access
- 6 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 84
The latest methods of treating type 1 diabetes, improving patients' quality of life – a review of the literature
Introduction: Type 1 diabetes is a chronic autoimmune disease characterized by destruction of pancreatic β cells and resultant absolute insulin deficiency. Despite advances in insulin delivery systems and glucose monitoring, patients remain at risk for severe acute and chronic complicationsConsequently, new approaches are being intensively developed, including cell-, gene-, and immunology-based therapies. Aim of the Study: The purpose of this study is to investigate new therapies used in type diabetes that may reduce the need for exogenous insulin. Materials and Methods: An analysis of papers available in PubMed was performed. Basic results: In recent years, many modern treatment methods have been studied, including the use of anti-CD3 antibodies. In November 2022, teplizumab (an anti-CD3 antibody) was approved as a drug that, by slowing the autoimmune destruction of pancreatic β cells, prolongs endogenous insulin production and delays the need for intensive insulin therapy. Another intensively investigated approach is pancreatic islet transplantation. The latest research results show that pancreatic islet transplantation improves glycemic control, prevents severe episodes of hypoglycemia, and makes some patients insulin-independent. In addition, results from 2024 on the first-ever transplantation of pancreatic islets derived from chemically induced pluripotent stem cells (CiPSCs) suggest that this treatment may be a personalized therapeutic strategy for patients with type 1 diabetes. However, further studies with a larger number of patients and longer follow-up periods are needed to assess the long-term safety and efficacy of this method. Conclusion: None of the existing therapies for type 1 diabetes is entirely optimal. Rapid scientific advances and emerging stem cell transplantation technologies offer patients hope for improved quality of life through better glycemic control, prevention of severe hypoglycemic episodes, and insulin independence.
- 6 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 84
Open AccessThe latest methods of treating type 1 diabetes, improving patients' quality of life – a review of the literature
Introduction: Type 1 diabetes is a chronic autoimmune disease characterized by destruction of pancreatic β cells and resultant absolute insulin deficiency. Despite advances in insulin delivery systems and glucose monitoring, patients remain at risk for severe acute and chronic complicationsConsequently, new approaches are being intensively developed, including cell-, gene-, and immunology-based therapies. Aim of the Study: The purpose of this study is to investigate new therapies used in type diabetes that may reduce the need for exogenous insulin. Materials and Methods: An analysis of papers available in PubMed was performed. Basic results: In recent years, many modern treatment methods have been studied, including the use of anti-CD3 antibodies. In November 2022, teplizumab (an anti-CD3 antibody) was approved as a drug that, by slowing the autoimmune destruction of pancreatic β cells, prolongs endogenous insulin production and delays the need for intensive insulin therapy. Another intensively investigated approach is pancreatic islet transplantation. The latest research results show that pancreatic islet transplantation improves glycemic control, prevents severe episodes of hypoglycemia, and makes some patients insulin-independent. In addition, results from 2024 on the first-ever transplantation of pancreatic islets derived from chemically induced pluripotent stem cells (CiPSCs) suggest that this treatment may be a personalized therapeutic strategy for patients with type 1 diabetes. However, further studies with a larger number of patients and longer follow-up periods are needed to assess the long-term safety and efficacy of this method. Conclusion: None of the existing therapies for type 1 diabetes is entirely optimal. Rapid scientific advances and emerging stem cell transplantation technologies offer patients hope for improved quality of life through better glycemic control, prevention of severe hypoglycemic episodes, and insulin independence.
- Open Access
- 16 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 82, 60329
Role of ketogenic and low-carbohydrate diets in the pathogenesis and treatment of obesity and diabetes mellitus type 1 and 2 - A Literature Review
Introduction: Ketogenic and low-carbohydrate diets are characterized by a significant reduction in daily carbohydrate intake, resulting in ketone bodies becoming an alternative energy source to glucose. Studies over the past decade have confirmed the therapeutic potential of the ketogenic diet in such disease entities as diabetes, polycystic ovary syndrome, acne, cancer, neurological diseases. In recent years, there has been a marked increase in patients with obesity and diabetes mellitus type 2, which has increased the number of studies on the impact of a carbohydrate-restricted diet on the pathogenesis and therapeutic process in this disease. This paper comprehensively analyzes the pathogenesis of obesity, diabetes mellitus type 1 and 2, and the effect of carbohydrate-restricted diet on these disease. Aim of the Study: The purpose of this study is to examine the effects of low-carbohydrate and ketogenic diets on the pathogenesis and treatment of obesity, type 1 and 2 diabetes mellitus. Materials and Methods: An analysis of papers available in PubMed was performed. The following keywords were used : non-carbohydrate diet, ketogenic diet, obesity, diabeletes mellutis type 1, diabetes mellutis type 2 Basic results: The ketogenic diet has a proven effective effect in reducing body weight, and thus shows a preventive effect on the development of type 2 diabetes. Low-carbohydrate diets improve glucose control and lower HbA1c levels. In addition, such a dietary pattern can help reduce the dose of hypoglycemic medications. Conclusion: According to the recommendations, there is no single optimal nutritional model in patients with diabetes, while the use of low-carbohydrate and ketogenic diets can lead to the desired results and achieve therapeutic goals in patients with diabetes.
- 16 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 82, 60329
Open AccessRole of ketogenic and low-carbohydrate diets in the pathogenesis and treatment of obesity and diabetes mellitus type 1 and 2 - A Literature Review
Introduction: Ketogenic and low-carbohydrate diets are characterized by a significant reduction in daily carbohydrate intake, resulting in ketone bodies becoming an alternative energy source to glucose. Studies over the past decade have confirmed the therapeutic potential of the ketogenic diet in such disease entities as diabetes, polycystic ovary syndrome, acne, cancer, neurological diseases. In recent years, there has been a marked increase in patients with obesity and diabetes mellitus type 2, which has increased the number of studies on the impact of a carbohydrate-restricted diet on the pathogenesis and therapeutic process in this disease. This paper comprehensively analyzes the pathogenesis of obesity, diabetes mellitus type 1 and 2, and the effect of carbohydrate-restricted diet on these disease. Aim of the Study: The purpose of this study is to examine the effects of low-carbohydrate and ketogenic diets on the pathogenesis and treatment of obesity, type 1 and 2 diabetes mellitus. Materials and Methods: An analysis of papers available in PubMed was performed. The following keywords were used : non-carbohydrate diet, ketogenic diet, obesity, diabeletes mellutis type 1, diabetes mellutis type 2 Basic results: The ketogenic diet has a proven effective effect in reducing body weight, and thus shows a preventive effect on the development of type 2 diabetes. Low-carbohydrate diets improve glucose control and lower HbA1c levels. In addition, such a dietary pattern can help reduce the dose of hypoglycemic medications. Conclusion: According to the recommendations, there is no single optimal nutritional model in patients with diabetes, while the use of low-carbohydrate and ketogenic diets can lead to the desired results and achieve therapeutic goals in patients with diabetes.
- 27 April 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (2)
The role of the ketogenic diet in the treatment of epilepsy in children and adolescents - a review of the literature
Introduction: Epilepsy affects around 50 million people worldwide and is marked by recurrent seizures due to abnormal brain activity. While anticonvulsant medication (ASM) is the standard treatment, about 30% of patients develop drug-resistant epilepsy (DRE), requiring alternative therapies. One such approach is the ketogenic diet (KD), a high-fat, low-carbohydrate regimen that mimics fasting metabolism. Recent research has explored its mechanisms and efficacy in epilepsy management. Aim of the Study: This study evaluates the effectiveness and mechanisms of KD in treating drug-resistant epilepsy in children and adolescents. Materials and Methods: A PubMed analysis was conducted using keywords: ketogenic diet, epilepsy, drug-resistant epilepsy, seizure control, metabolic therapy. Basic Results: Studies confirm KD’s ability to reduce seizure frequency and severity in children with DRE. Over 50% of patients on KD show significant seizure reduction, with some achieving complete freedom. Though side effects like gastrointestinal discomfort and dyslipidemia occur, they are generally manageable. EEG studies suggest KD improves epileptiform discharges, offering broader neurological benefits. Conclusion: KD is a proven, effective therapy for DRE in children, working through increased GABAergic inhibition, metabolic shifts, and neuroprotection. Clinical trials show its ability to reduce seizures, enhance cognition, and improve EEG patterns. While adherence can be difficult, modified versions like MAD offer flexibility. KD’s long-term safety is acceptable, with manageable side effects. Future research should explore its potential as a primary therapy, reducing reliance on ASMs.
- 27 April 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (2)
The role of the ketogenic diet in the treatment of epilepsy in children and adolescents - a review of the literature
Introduction: Epilepsy affects around 50 million people worldwide and is marked by recurrent seizures due to abnormal brain activity. While anticonvulsant medication (ASM) is the standard treatment, about 30% of patients develop drug-resistant epilepsy (DRE), requiring alternative therapies. One such approach is the ketogenic diet (KD), a high-fat, low-carbohydrate regimen that mimics fasting metabolism. Recent research has explored its mechanisms and efficacy in epilepsy management. Aim of the Study: This study evaluates the effectiveness and mechanisms of KD in treating drug-resistant epilepsy in children and adolescents. Materials and Methods: A PubMed analysis was conducted using keywords: ketogenic diet, epilepsy, drug-resistant epilepsy, seizure control, metabolic therapy. Basic Results: Studies confirm KD’s ability to reduce seizure frequency and severity in children with DRE. Over 50% of patients on KD show significant seizure reduction, with some achieving complete freedom. Though side effects like gastrointestinal discomfort and dyslipidemia occur, they are generally manageable. EEG studies suggest KD improves epileptiform discharges, offering broader neurological benefits. Conclusion: KD is a proven, effective therapy for DRE in children, working through increased GABAergic inhibition, metabolic shifts, and neuroprotection. Clinical trials show its ability to reduce seizures, enhance cognition, and improve EEG patterns. While adherence can be difficult, modified versions like MAD offer flexibility. KD’s long-term safety is acceptable, with manageable side effects. Future research should explore its potential as a primary therapy, reducing reliance on ASMs.
- Open Access
- 10 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 38, 58150
Are Artificial Sweeteners a Healthier Alternative to Sugar?
Introduction Sweeteners are a common sugar alternative, especially in combating obesity and diabetes. With low calorie content, they appeal to health-conscious individuals. The food industry uses natural options like stevia or erythritol and synthetic ones such as aspartame or saccharin. While recognized as safe at recommended doses, debates continue about their long-term effects, emphasizing the need for further research. This paper explores the properties, benefits, and risks of sweeteners. Aim of the Study This study examines the effects of sweeteners on human health and evaluates their suitability as sugar substitutes for modern consumers, highlighting their benefits and potential risks. Materials and Methods An analysis of PubMed papers was conducted using keywords: sweeteners, artificial sweeteners, erythritol, acesulfame potassium, sucralose, aspartame, and sugar alternatives. Basic Results Both natural and synthetic sweeteners are used as sugar substitutes to address concerns about excessive sugar intake. Research indicates they help reduce calorie consumption and control blood sugar levels. However, uncertainties remain about their long-term health effects. Some studies suggest possible changes in metabolism or gut microbiota, but evidence is inconclusive. Regulatory bodies like the FDA deem approved sweeteners safe within recommended daily limits. Despite their advantages, further research is needed to fully understand their long-term impact. Conclusion Sweeteners are gaining popularity as sugar alternatives, particularly in the context of obesity and diabetes. Their variety allows for diverse dietary applications. While safe within recommended doses, questions about their long-term effects persist. They aid in weight control and glucose regulation but are not universally suitable. A balanced approach and further research are crucial.
- 10 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 38, 58150
Open AccessAre Artificial Sweeteners a Healthier Alternative to Sugar?
Introduction Sweeteners are a common sugar alternative, especially in combating obesity and diabetes. With low calorie content, they appeal to health-conscious individuals. The food industry uses natural options like stevia or erythritol and synthetic ones such as aspartame or saccharin. While recognized as safe at recommended doses, debates continue about their long-term effects, emphasizing the need for further research. This paper explores the properties, benefits, and risks of sweeteners. Aim of the Study This study examines the effects of sweeteners on human health and evaluates their suitability as sugar substitutes for modern consumers, highlighting their benefits and potential risks. Materials and Methods An analysis of PubMed papers was conducted using keywords: sweeteners, artificial sweeteners, erythritol, acesulfame potassium, sucralose, aspartame, and sugar alternatives. Basic Results Both natural and synthetic sweeteners are used as sugar substitutes to address concerns about excessive sugar intake. Research indicates they help reduce calorie consumption and control blood sugar levels. However, uncertainties remain about their long-term health effects. Some studies suggest possible changes in metabolism or gut microbiota, but evidence is inconclusive. Regulatory bodies like the FDA deem approved sweeteners safe within recommended daily limits. Despite their advantages, further research is needed to fully understand their long-term impact. Conclusion Sweeteners are gaining popularity as sugar alternatives, particularly in the context of obesity and diabetes. Their variety allows for diverse dietary applications. While safe within recommended doses, questions about their long-term effects persist. They aid in weight control and glucose regulation but are not universally suitable. A balanced approach and further research are crucial.
- Open Access
- 11 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 57223
The Role of Inflammatory Cytokines and lncRNAs in the Pathogenesis of Atherosclerosis and Other Inflammatory Diseases: Focus on Sarcoidosis and Alzheimer’s Disease
Introduction Atherosclerosis, a chronic inflammatory disease of the arterial wall, remains a leading cause of morbidity and mortality worldwide. Recent advances highlight the role of inflammatory cytokines and long non-coding RNAs (lncRNAs) in its pathogenesis. Aim of the Study This study synthesizes current knowledge on the interplay between cytokines and lncRNAs across these conditions, emphasizing their potential as biomarkers and therapeutic targets. Materials and Methods Through a systematic review of recent studies, we identify key pathways and discuss translational implications for novel interventions. Description of the State of Knowledge Inflammatory cytokines, including interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6), orchestrate immune responses that exacerbate endothelial dysfunction, foam cell formation, and plaque instability. Concurrently, lncRNAs regulate gene expression through transcriptional and post-transcriptional mechanisms, influencing cellular processes such as macrophage polarization and smooth muscle cell proliferation. Beyond atherosclerosis, these mediators are implicated in the pathogenesis of other inflammatory diseases, including sarcoidosis and Alzheimer's disease. Conclusion Our findings underscore the critical need for integrated approaches targeting both inflammatory mediators and epigenetic regulators to mitigate the burden of these diseases.
- 11 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 57223
Open AccessThe Role of Inflammatory Cytokines and lncRNAs in the Pathogenesis of Atherosclerosis and Other Inflammatory Diseases: Focus on Sarcoidosis and Alzheimer’s Disease
Introduction Atherosclerosis, a chronic inflammatory disease of the arterial wall, remains a leading cause of morbidity and mortality worldwide. Recent advances highlight the role of inflammatory cytokines and long non-coding RNAs (lncRNAs) in its pathogenesis. Aim of the Study This study synthesizes current knowledge on the interplay between cytokines and lncRNAs across these conditions, emphasizing their potential as biomarkers and therapeutic targets. Materials and Methods Through a systematic review of recent studies, we identify key pathways and discuss translational implications for novel interventions. Description of the State of Knowledge Inflammatory cytokines, including interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6), orchestrate immune responses that exacerbate endothelial dysfunction, foam cell formation, and plaque instability. Concurrently, lncRNAs regulate gene expression through transcriptional and post-transcriptional mechanisms, influencing cellular processes such as macrophage polarization and smooth muscle cell proliferation. Beyond atherosclerosis, these mediators are implicated in the pathogenesis of other inflammatory diseases, including sarcoidosis and Alzheimer's disease. Conclusion Our findings underscore the critical need for integrated approaches targeting both inflammatory mediators and epigenetic regulators to mitigate the burden of these diseases.
- 26 December 2024
- Published by European Scientific Society in Archiv Euromedica
- Vol. 12 (6)
Electroconvulsive Therapy - History and Current Use in Psychiatry: A Literature Review
Despite the numerous controversies associated with electroconvulsive therapy, in its favor is the relatively low number of contraindications, side effects and high level of safety. Purpose: The purpose of the publication was to collect and organize information on the use of electroconvulsive therapy in psychiatry and its effectiveness in specific disease entities, such as depression, schizophrenia, bipolar affective disorder and PTSD. Methods: A literature review was conducted using PubMed and Google Scholar containing information on the use of ECT in psychiatry. The search focused on the words electroconvulsive therapy, ECT, schizophrenia, depression, PTSD, bipolar affective disorder. Priority was given to using recent articles. Results: According to the most reliable sources, electroconvulsive therapy has a beneficial therapeutic effect in patients with depression, PTSD, schizophrenia and bipolar affective disorder. Conclusions: Due to the commonness of mental illnesses and the co-occurring resistance to pharmacological treatment, modern psychiatry is looking for alternative methods. One of them is electroconvulsive therapy, which has undergone modifications over time and is today considered a method with a high safety profile. Beneficial effects of the use of ECT can be observed in patients with bipolar disorder, schizophrenia and depression, and research on its effectiveness in the case of PTSD is still ongoing. ECT can be used in pregnant women, in patients with treatment-resistant depression and at high risk of suicide.
- 26 December 2024
- Published by European Scientific Society in Archiv Euromedica
- Vol. 12 (6)
Electroconvulsive Therapy - History and Current Use in Psychiatry: A Literature Review
Despite the numerous controversies associated with electroconvulsive therapy, in its favor is the relatively low number of contraindications, side effects and high level of safety. Purpose: The purpose of the publication was to collect and organize information on the use of electroconvulsive therapy in psychiatry and its effectiveness in specific disease entities, such as depression, schizophrenia, bipolar affective disorder and PTSD. Methods: A literature review was conducted using PubMed and Google Scholar containing information on the use of ECT in psychiatry. The search focused on the words electroconvulsive therapy, ECT, schizophrenia, depression, PTSD, bipolar affective disorder. Priority was given to using recent articles. Results: According to the most reliable sources, electroconvulsive therapy has a beneficial therapeutic effect in patients with depression, PTSD, schizophrenia and bipolar affective disorder. Conclusions: Due to the commonness of mental illnesses and the co-occurring resistance to pharmacological treatment, modern psychiatry is looking for alternative methods. One of them is electroconvulsive therapy, which has undergone modifications over time and is today considered a method with a high safety profile. Beneficial effects of the use of ECT can be observed in patients with bipolar disorder, schizophrenia and depression, and research on its effectiveness in the case of PTSD is still ongoing. ECT can be used in pregnant women, in patients with treatment-resistant depression and at high risk of suicide.